Search
for
Sort by
Research 241–270 of 252
- Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Self-Reported Hair Loss Following COVID-19: An Observational Study
- A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection
- Потеря волос, ассоциированная с COVID‑19: проблема и пути решения
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- Dermatological manifestations of COVID-19 and its therapies: a review
- Pharmacogenetics of the Androgen Metabolic Pathway
- Androgenetic alopecia and coronavirus infection
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- TMPRSS2, required for SARS-CoV-2 entry, is downregulated in lung cells by enzalutamide, a prostate cancer therapeutic
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Vitamin D And Tmprss2: Intersecting Pathways In Post-Covid-19 Alopecia
- Finasteride Induces Epigenetic Alteration of TMPRss2 Gene Expression: A Potential role in Severe Acute Respiratory Syndrome-Corona Virus-2 Inhibition
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Is COVID-19 Gender-sensitive?
- ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
- Cutaneous signs in COVID ‐19 patients: A review
- Androgen sensitivity gateway to COVID‐19 disease severity